← Back

Which supplements actually help you live longer

Treating a deficiency, improving sleep and extending life are different goals. The case for a supplement depends on which of those jobs it has been tested to do.

A supplement label may promise energy, hormone support and healthy ageing in the same paragraph. The ingredients beneath it can have quite different evidence: an established role in treating deficiency, a small trial reporting better sleep, or no convincing human benefit at all.

For a reader interested in longevity, the distinction is consequential. Improving a blood measurement or correcting a nutritional gap is not the same as showing that a product reduces illness or extends life.

Some of the largest studies help set expectations. In VITAL, 25,871 adults were randomly assigned vitamin D, marine omega-3 fatty acids, both or placebo. Over a median 5.3 years, neither supplement reduced the primary endpoints of invasive cancer or major cardiovascular events. Some secondary findings were more favourable, but the trial did not establish either product as a general life-extension treatment.

25,871Adults in VITAL, randomised to vitamin D, omega-3, both, or neither
5.3 yrsMedian follow-up. Neither supplement cut invasive cancer or major cardiovascular events
390,124Healthy US adults in a 2024 NIH analysis of daily multivitamins and death
No dropDaily multivitamin use was not linked to lower all-cause, heart, or cancer mortality

A 2024 analysis of 390,124 US adults found no evidence that regular multivitamin use was associated with improved longevity. It was observational, so it cannot settle every question about supplementation. It does challenge the assumption that a daily multivitamin will help an otherwise healthy adult live longer.

Deficiency changes the question

Vitamin D is needed for calcium absorption and bone health. Treating a deficiency has a clear nutritional purpose. In contrast, the vitamin D arm of VITAL tested 2,000 IU a day in a population not selected for deficiency and found no reduction in its primary cancer and cardiovascular outcomes. An ancillary study also found no reduction in fractures.

Those results do not mean nobody needs vitamin D. They mean that the benefits of treating a nutritional problem cannot be assumed for everyone taking the same nutrient. Requirements depend on factors including diet, age, medical history and the relevant clinical guidance.

Zinc has established roles in immune function, wound healing and protein synthesis. The NIH fact sheet gives adult recommended intakes of 11 mg a day for men and 8 mg for women. More is not necessarily beneficial: prolonged high intake can impair copper absorption. The US adult upper limit is 40 mg a day from all sources, apart from medically supervised treatment.

Vitamin B12 supplementation can be important for people who do not obtain enough from food or cannot absorb it adequately. That is another specific use, rather than evidence for a universal anti-ageing formula.

Performance and healthspan outcomes

Creatine has evidence for improving aspects of resistance-training performance. For people trying to maintain strength as they age, that can be a useful outcome. Human research has not established that taking it extends lifespan. The creatine review covers its uses separately.

Omega-3 supplements require similar care in interpretation. The VITAL omega-3 trial did not reduce the primary composite cardiovascular endpoint, although some secondary outcomes, including myocardial infarction, were lower. Prescription products used for particular conditions should not be treated as interchangeable with an over-the-counter capsule. Neither should supplement results be substituted for research on eating fish.

For any product, the relevant questions are what outcome was measured, in whom, for how long and at what dose. A short strength trial may be useful without answering a longevity question.

Looking closely at a typical vitality formula

Formulas marketed to men often combine minerals with herbs and amino acids. The mixture can sound more persuasive than the evidence for its individual components.

Evidence for a typical vitality stack Horizontal bars ranking common vitality-stack ingredients by strength of human evidence for healthspan, from vitamin D and zinc for deficiency, through ashwagandha for stress, down to D-aspartic acid and vitamin B5 with little supporting evidence. EVIDENCE FOR SPECIFIC USES Benefits depend on the ingredient, population and outcome studied. Vitamin D deficiency / bone Zinc if intake is low Ashwagandha stress / sleep Garlic modest BP drop Green tea drink, not extract Fenugreek small T trials Ginseng mixed, short trials D-aspartic acid inconsistent results Vitamin B5 nutritional role
An editorial overview of selected ingredients and their studied uses. Bar lengths are qualitative assessments, not measured effect sizes or a validated ranking of longevity benefits.

The chart is an editorial summary of different kinds of evidence. Its bars are not a validated scoring system, and a higher position does not represent a measured increase in lifespan.

IngredientWhat the evidence can supportImportant limitation
D-aspartic acidStudied for effects on testosteroneTrials in trained men have not consistently found a benefit; a hormone claim does not establish healthier ageing
AshwagandhaSome small trials report improvements in stress or sleepPreparations vary, long-term safety is uncertain, and liver and thyroid effects require attention
FenugreekSome trials and a meta-analysis report testosterone changesStudies of particular extracts do not establish that a blended product improves longevity
Panax ginsengLimited research on fatigue and some sexual-function outcomesTrials are often small and short; insomnia and medication interactions are relevant
Garlic extractsSome evidence of modest blood-pressure or lipid effectsProducts and doses differ, and effects on markers are not proof of longer life
Green-tea extractsStudied for metabolic outcomesConcentrated extracts have been linked to liver injury; they are different from brewed tea
PomegranateResearch on specific cardiovascular markersThe presence of an extract in a formula does not establish a useful dose or a survival benefit
Vitamins B5 and B6Essential nutrients with defined dietary rolesExtra intake is not an established longevity treatment; excessive supplemental B6 can cause nerve damage

A systematic review of testosterone boosters found that most examined products or ingredients did not increase total testosterone. Even a reliable hormone change would need further research to establish effects on strength, wellbeing or long-term health. Testosterone is not a direct measure of ageing.

Safety needs to be assessed ingredient by ingredient

The NIH review of ashwagandha describes possible benefits alongside reports of liver injury and effects on thyroid function. It may be unsuitable during pregnancy and for people with some medical conditions or medicines. A short study reporting benefit does not resolve those concerns.

Ginseng, fenugreek, garlic and other ingredients can interact with medicines, including those affecting blood sugar or clotting. Combining several ingredients makes it harder to identify the cause of a side effect. A clinician or pharmacist can assess the actual label alongside someone’s medication list.

The regulatory position matters too. In the United States, supplements are not generally approved by the FDA for safety and effectiveness before sale. Availability is therefore not equivalent to proof of benefit.

For someone considering a supplement, a useful decision begins with a defined need: an identified nutritional gap, a condition being treated or a performance goal supported by relevant evidence. It should include an appropriate dose and a way to assess whether the product is helping.

Large trials give little support to buying a broad supplement formula simply to live longer. That leaves room for specific products with specific uses, provided their benefits and risks are judged on those terms.

Editorial note: Revised on 6 October 2026 with AI-assisted editing.

Sources